Repositorio Digital de la UPF
Publication
Artículo científico (JournalArticle)
Engineering the auxin-inducible degron system for tunable in vivo control of organismal physiology
The auxin-inducible degron (AID) system is designed for the rapid and near-complete degradation of a specific target protein in vivo. However, to understand the dynamics of complex physiological networks, researchers often need methods that produce graded, quantitative changes in degradation rates for multiple proteins simultaneously. Here, we develop the AID system for in vivo, quantitative control over the abundance of multiple proteins simultaneously. First, by measuring and modeling the on- and off-target activities of different AID system variants in Caenorhabditis elegans, we characterize a variant of the E3 ubiquitin ligase subunit TIR1, which provides improved degradation activity compared to the original AID and AID2 systems. Then, we develop a TIR1 expression construct that enables simultaneous pan-somatic and germline protein degradation. Finally, we expand the AID toolkit to allow independent, simultaneous degradation of two distinct tissue-specific proteins. Together, these technologies enable new in vivo approaches for studying quantitative cellular biology and organismal dynamics., This work was technically supported by the EMBL Genomics Core facility. Research for this publication has been partially conducted at the Barcelona Collaboratorium for Modeling and Predictive Biology. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), the Generalitat de Catalunya through the CERCA program, and the EMBL partnership. We acknowledge support from the Spanish Ministry of Economy, Industry and Competitiveness, project BFU2017-88615-P, co-funded by the European Regional Development Fund (ERDF, EU), and the Spanish Ministry of Science and Innovation (MICIN/AEI/10.13039/501100011033), project PID2020-115189GB-I00, and co-funded by ERDF, EU. These results are part of a project that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (Grant agreement No. 852201). J.A. acknowledges funding from Wellcome (217170) and the Medical Research Council (MR/S021620/1).